Michael V Cohen

6PUBLICATIONS
1CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Molecular targetsContext learningCancer therapy (excl. chemotherapy and radiation therapy)Clinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 25, 2024
Initial Despair and Current Hope of Identifying a Clinically Useful Treatment of Myocardial Reperfusion Injury: Insights Derived from Studies of Platelet P2Y12 Antagonists and Interference with Inflammation and NLRP3 Assembly.

Michael V Cohen, James M Downey

|Feb 25, 2023
Lethal Caspase-1/4-Dependent Injury Occurs in the First Minutes of Coronary Reperfusion and Requires Calpain Activity.

Xi-Ming Yang, Michael V Cohen, Sarah Sayner

|Oct 11, 2022
Remote Ischemic Conditioning: more explanations and more expectations.

Efstathios K Iliodromitis, Michael V Cohen, James M Downey

|Jul 15, 2021
The Role of Pyroptosis in Ischemic and Reperfusion Injury of the Heart.

Sergey V Popov, Leonid N Maslov, Natalia V Naryzhnaya

|Oct 25, 2019
What Are Optimal P2Y12 Inhibitor and Schedule of Administration in Patients With Acute Coronary Syndrome?

Michael V Cohen, James M Downey

|Feb 13, 2019
Ticagrelor Does Not Protect Isolated Rat Hearts, Thus Clouding Its Proposed Cardioprotective Role Through ENT 1 in Heart Tissue.

Xi-Ming Yang, Sushee Gadde, Jonathon P Audia

Pageof 1

Frequent Collaborators

1 joint publications

Leonid N Maslov